Jang, Sung Jae
Park, SungJun
Lee, Kiuk
Kim, Woon-Ki
Moon, Sung Hyun
Cho, Bo-Ram
Lee, Cheonghoon
Lee, Hyungjin
Nam, Tae-Wook
Ko, GwangPyo
Funding for this research was provided by:
The Bio &Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (NRF-2022M3A9F3017371)
The Bio &Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (NRF-2022M3A9F3017371)
The Bio &Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (NRF-2022M3A9F3017371)
The Technology Innovation Program funded by the Ministry of Trade, Industry &Energy (MOTIE), Republic of Korea (10076742)
The Technology Innovation Program funded by the Ministry of Trade, Industry &Energy (MOTIE), Republic of Korea (10076742)
The Technology Innovation Program funded by the Ministry of Trade, Industry &Energy (MOTIE), Republic of Korea (10076742)
The Technology Innovation Program funded by the Ministry of Trade, Industry &Energy (MOTIE), Republic of Korea (10076742)
The Technology Innovation Program funded by the Ministry of Trade, Industry &Energy (MOTIE), Republic of Korea (10076742)
The Technology Innovation Program funded by the Ministry of Trade, Industry &Energy (MOTIE), Republic of Korea (10076742)
The Technology Innovation Program funded by the Ministry of Trade, Industry &Energy (MOTIE), Republic of Korea (10076742)
Article History
Received: 7 January 2025
Accepted: 3 February 2026
First Online: 16 February 2026
Competing interests
: G.K. is the chief executive officer of KoBioLabs, Inc. K.L., S.H.M., and B-R.C. are employees of KoBioLabs, Inc. H.L. is the chief executive officer of weBiom Inc. S.J.J. and S.P. are employees of weBiom Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.